Nuvation Bio (NUVB) Accumulated Expenses (2023 - 2025)
Historic Accumulated Expenses for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $32.6 million.
- Nuvation Bio's Accumulated Expenses rose 3859.87% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 3859.87%. This contributed to the annual value of $32.8 million for FY2024, which is 23527.01% up from last year.
- Latest data reveals that Nuvation Bio reported Accumulated Expenses of $32.6 million as of Q3 2025, which was up 3859.87% from $24.0 million recorded in Q2 2025.
- In the past 5 years, Nuvation Bio's Accumulated Expenses ranged from a high of $32.8 million in Q4 2024 and a low of $8.4 million during Q1 2023
- For the 3-year period, Nuvation Bio's Accumulated Expenses averaged around $18.9 million, with its median value being $20.0 million (2024).
- In the last 5 years, Nuvation Bio's Accumulated Expenses surged by 23527.01% in 2024 and then skyrocketed by 2014.62% in 2025.
- Nuvation Bio's Accumulated Expenses (Quarter) stood at $9.8 million in 2023, then surged by 235.27% to $32.8 million in 2024, then dropped by 0.77% to $32.6 million in 2025.
- Its last three reported values are $32.6 million in Q3 2025, $24.0 million for Q2 2025, and $23.9 million during Q1 2025.